LifeScan, Inc. is recalling all of its OneTouch® Verio®IQ blood glucose meters in the United States, effective immediately. LifeScan is recalling and replacing all of these meters because at extremely high blood glucose levels of 1024 mg/dL and above, the meter will not provide a warning that the blood glucose is extremely high and will shut off, thereby potentially leading to incorrect treatment and delaying proper treatment. The company says the likelihood of experiencing an extremely high blood glucose level of 1024 mg/dL or higher is remote. However, when such a blood glucose level occurs, it is a serious health risk requiring immediate medical attention. Because these products do not provide an appropriate warning at glucose levels of 1024 mg/dL or higher, diagnosis and treatment of extreme hyperglycemia may be delayed or incorrect treatment may be given resulting in potentially serious health risk or death.
Patients who are using the OneTouch® Verio®IQ Meter should contact LifeScan Customer Service at (800) 717-0276 to make arrangements to receive a replacement meter at no charge and to speak with a LifeScan representative. Representatives are available 8 a.m. to 10 p.m. EDT Monday through Sunday (LifeScan U.S. Customer Service). There is additional information about this recall on www.onetouch.com.
The company says that patients may continue to test with their OneTouch® Verio®IQ Meters while they wait for their replacement meter to arrive as long as they are aware of this issue. However, LifeScan advises that if the meter unexpectedly turns itself off during testing, this could be a sign of extreme hyperglycemia requiring immediate medical attention and the patient should call a healthcare professional. LifeScan estimates that there are approximately 90,000 active OneTouch® Verio®IQ Meter users in the U.S. The company is in the process of implementing an update to the meter to address the issue. The timing to resume shipments of OneTouch® Verio®IQ Meters, however, had not yet been determined at press time.
To date, the company says no adverse events or patient injuries related to this specific issue have been reported for the OneTouch® Verio®IQ Meter. All other OneTouch® blood glucose brands sold in the U.S., including OneTouch® Ultra® Meters, OneTouch® Select Meters and OneTouch® Verio® Test Strips, are not affected and the company says they can continue to be used.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.